In this study, we profiled the cytokine-chemokine serum levels associated with prostate cancer and demonstrated that serum chemokines CXCL2, CXCL5, and CCL23 are the most distinguished chemokines differentially expressed in men of AA and CA races. This evidence concerns the gene CXCL5 and prostate cancer.